← Open Payments lookup

DAVID LISKOV: Open Payments

NPI 1780683417 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$960 in 52 payments from 10 companies in 2025. Trend: 2023 $443 · 2024 $559 · 2025 $960

Food & beverage: $850Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.15$260
Otsuka America Pharmaceutical, Inc.10$174
E.R. Squibb & Sons, L.L.C.7$140
Vanda Pharmaceuticals Inc.5$117
Janssen Pharmaceuticals, Inc4$82
Neurocrine BioSciences, Inc.4$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$69
Sage Therapeutics, LLC1$21
Alkermes, Inc.1$19
Axsome Therapeutics, Inc.1$10

Products named: COBENFY, REXULTI, FANAPT, UZEDY, INGREZZA, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA.

Industry payments across PA — which companies pay providers there.